Fig. 8

Sensitivity analysis of anticancer drugs in different risk score subgroups. Sensitivity analysis of different risk score groups to Gemcitabine (A), Doxorubicin (B), Docetaxel (C), Cisplatin (D), Vinorelbine (E), Paclitaxel (F), MG132 (G), Methotrexate (H), Camptothecin (I). *p < 0.05, **p < 0.01, ***p < 0.001